Demars Financial Group LLC Decreases Stake in Medical Properties Trust, Inc. $MPW

Key Points

• Demars Financial Group LLC significantly decreased its stake in Medical Properties Trust, Inc. (MPW) by 67.3%, owning 105,305 shares post-sale, valued at approximately $454,000.
• Medical Properties Trust reported a quarterly loss with earnings per share of $0.14, missing the expected $0.15, and a 9.8% decrease in revenue compared to the previous year.
• The company announced a quarterly dividend of $0.08, resulting in an annualized dividend yield of 6.2%, despite a negative dividend payout ratio of -13.39%.

Demars Financial Group LLC reduced its position in Medical Properties Trust, Inc. (NYSE:MPW - Free Report) by 67.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 105,305 shares of the real estate investment trust's stock after selling 216,408 shares during the period. Demars Financial Group LLC's holdings in Medical Properties Trust were worth $454,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MPW. Itau Unibanco Holding S.A. purchased a new position in Medical Properties Trust in the 1st quarter valued at about $41,000. Drive Wealth Management LLC acquired a new stake in shares of Medical Properties Trust in the 2nd quarter valued at about $45,000. Farther Finance Advisors LLC raised its stake in shares of Medical Properties Trust by 49.5% in the 1st quarter. Farther Finance Advisors LLC now owns 7,875 shares of the real estate investment trust's stock valued at $47,000 after purchasing an additional 2,606 shares in the last quarter. Apollon Wealth Management LLC acquired a new stake in shares of Medical Properties Trust in the 2nd quarter valued at about $47,000. Finally, Twin Tree Management LP acquired a new stake in shares of Medical Properties Trust in the 1st quarter valued at about $48,000. 71.79% of the stock is owned by hedge funds and other institutional investors.

Medical Properties Trust Price Performance

MPW opened at $5.15 on Monday. The firm has a market cap of $3.10 billion, a price-to-earnings ratio of -2.15 and a beta of 1.39. Medical Properties Trust, Inc. has a fifty-two week low of $3.51 and a fifty-two week high of $6.34. The company's 50-day moving average price is $4.76 and its 200 day moving average price is $4.71. The company has a quick ratio of 2.76, a current ratio of 2.76 and a debt-to-equity ratio of 2.00.

Medical Properties Trust (NYSE:MPW - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). The business had revenue of $240.36 million for the quarter, compared to analyst estimates of $231.90 million. Medical Properties Trust had a negative return on equity of 28.80% and a negative net margin of 155.20%.Medical Properties Trust's revenue was down 9.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.23 EPS. As a group, sell-side analysts expect that Medical Properties Trust, Inc. will post 0.78 earnings per share for the current year.

Medical Properties Trust Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, October 9th. Shareholders of record on Thursday, September 11th were given a $0.08 dividend. The ex-dividend date was Thursday, September 11th. This represents a $0.32 annualized dividend and a yield of 6.2%. Medical Properties Trust's dividend payout ratio is -13.39%.

Wall Street Analyst Weigh In

MPW has been the topic of a number of recent analyst reports. Zacks Research upgraded shares of Medical Properties Trust from a "strong sell" rating to a "hold" rating in a research note on Wednesday, August 20th. Wall Street Zen lowered shares of Medical Properties Trust from a "hold" rating to a "sell" rating in a research note on Saturday, July 5th. Royal Bank Of Canada cut their target price on shares of Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating on the stock in a research note on Monday, June 30th. Wells Fargo & Company cut their target price on shares of Medical Properties Trust from $5.00 to $4.50 and set an "underweight" rating on the stock in a research note on Wednesday, August 27th. Finally, Weiss Ratings restated a "sell (d-)" rating on shares of Medical Properties Trust in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Reduce" and a consensus target price of $5.40.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.

Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.